Performance and Use of a Ribonucleotide Reductase Herpes Simplex Virus Type-Specific Serological Assay
- 1 January 2004
- journal article
- research article
- Published by American Society for Microbiology in Clinical and Vaccine Immunology
- Vol. 11 (1) , 42-9
- https://doi.org/10.1128/cdli.11.1.42-49.2004
Abstract
In response to the increasingly evident need for herpes simplex virus (HSV) serotype-specific serologic assays that rely on proteins other than glycoprotein-G (gG), we developed a rapid serologic assay that is based on type-specific epitopes within the large subunit of HSV ribonucleotide reductase (R1). The assay (Au-2 enzyme-linked immunosorbent assay [ELISA]) uses an HSV type 2 (HSV-2) R1 peptide antigen. It provides a reliable method for detecting serotype-specific antibody to a protein other than gG-2. The Au-2 ELISA has high sensitivity and specificity as determined by direct comparison to Western blotting, a widely accepted “gold standard,” and to ELISA with an HSV-1 R1 peptide (Au-1). The use of the Au-2 ELISA in conjunction with the gG-2-based assays will improve the sensitivity and specificity of serologic diagnosis and patient management.Keywords
This publication has 52 references indexed in Scilit:
- The Herpes Simplex Virus Type 2 R1 Protein Kinase (ICP10 PK) Functions as a Dominant Regulator of Apoptosis in Hippocampal Neurons Involving Activation of the ERK Survival Pathway and Upregulation of the Antiapoptotic Protein Bag-1Journal of Virology, 2003
- Seroprevalence and Correlates of Herpes Simplex Virus Type 2 Infection in Five Sexually Transmitted–Disease ClinicsThe Journal of Infectious Diseases, 2002
- Performance of Two Commercial Glycoprotein G-Based Enzyme Immunoassays for Detecting Antibodies to Herpes Simplex Viruses 1 and 2 in Children and Young AdolescentsClinical and Vaccine Immunology, 2002
- Evaluation of Confirmatory Strategies for Detection of Type-Specific Antibodies against Herpes Simplex Virus Type 2Journal of Clinical Microbiology, 2002
- A growth and latency compromised herpes simplex virus type 2 mutant (ICP10ΔPK) has prophylactic and therapeutic protective activity in guinea pigsVaccine, 2001
- Herpes Simplex Virus Type 2 Growth and Latency Reactivation by Cocultivation Are Inhibited with Antisense Oligonucleotides Complementary to the Translation Initiation Site of the Large Subunit of Ribonucleotide Reductase (RR1)Antisense and Nucleic Acid Drug Development, 2000
- Frequent genital herpes simplex virus 2 shedding in immunocompetent women. Effect of acyclovir treatment.Journal of Clinical Investigation, 1997
- Evaluation of a Test Based on Baculovirus-Expressed Glycoprotein G for Detection of Herpes Simplex Virus Type-Specific AntibodiesThe Journal of Infectious Diseases, 1991
- Leucine repeats in the large subunit of herpes simplex virus type 2 ribonucleotide reductase (RR; ICP10) are involved in RR activity and subunit complex formationJournal of General Virology, 1991
- Sequential genital infections with herpes simplex virus types 1 and 2.Sexually Transmitted Infections, 1989